Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with Haemophilus influenzae Meningitis in a Newborn

• Published in: Current issues in molecular biology Vol. 45; no. 9; pp. 6958 - 6966
• Main Authors: Ferreira, Noely Evangelista, da Costa, Antonio C., Kallas, Esper G., Silveira, Cassia G. T., de Oliveira, Ana Carolina S., Honorato, Layla, Paião, Heuder G. O., Lima, Silvia H., de M. Vasconcelos, Dewton, Côrtes, Marina F., Costa, Silvia F., Mendoza, Tania R. T., Gomes, Hélio R., Witkin, Steven S., Mendes-Correa, Maria C.
• Format: Journal Article
• Language: English
• Published: MDPI 01.09.2023; MDPI AG
• Subjects: Case Report; encephalopathy; human parvovirus B19; metagenomic next-generation sequencing
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb45090439

Parvovirus B19 infection is associated with a wide range of clinical manifestations, from asymptomatic to severe neurological disorders. Its major clinical symptoms, fever and rash, are common to multiple viruses, and laboratory tests to detect B19 are frequently not available. Thus, the impact of B19 on public health remains unclear. We report the case of a 38-day old girl admitted to São Paulo Clinical Hospital, Brazil, with an initial diagnosis of bacterial meningitis, seizures, and acute hydrocephalus. Antibiotic therapy was maintained for one week after admission and discontinued after negative laboratory results were obtained. Nine days after symptoms onset, a cerebral spinal fluid (CSF) sample revealed persistent pleocytosis. The complete B19 complete genome was subsequently identified in her CSF by a metagenomic next-generation sequencing approach. This report highlights the possible involvement of B19 in the occurrence of acute neurological manifestations and emphasizes that its possible involvement might be better revealed by the use of metagenomic technology to detect viral agents in clinical situations of unknown or uncertain etiology.